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Abstract
Background: Relapse is common among recovered anorexia nervosa (AN) patients. Studies on relapse prevention
with an average follow-up period of 18 months found relapse rates between 35 and 41 %. In leading guidelines
there is general consensus that relapse prevention in patients treated for AN is a matter of essence. However, lack
of methodological support hinders the practical implementation of relapse prevention strategies in clinical practice.
For this reason we developed the Guideline Relapse Prevention Anorexia Nervosa. In this study we examine the
rate, timing and predictors of relapse when using this guideline.
Method: Cohort study with 83 AN patients who were enrolled in a relapse prevention program for anorexia
nervosa with 18 months follow-up. Data were analyzed using Kaplan-Meijer survival analyses and Cox regression.
Results: Eleven percent of the participants experienced a full relapse, 19 % a partial relapse, 70 % did not relapse.
Survival analyses indicated that in the first four months of the program no full relapses occurred. The highest risk of
full relapse was between months 4 and 16. None of the variables remained a significant predictor of relapse in the
multivariate Cox regression analysis.
Conclusion: The guideline offers structured procedures for relapse prevention. In this study the relapse rates were
relatively low compared to relapse rates in previous studies. We recommend that all patients with AN set up a
personalized relapse prevention plan at the end of their treatment and be monitored at least 18 months after
discharge. It may significantly contribute to the reduction of relapse rates.
Keywords: Anorexia nervosa, Relapse, Relapse intervention, Relapse prevention, Survival analysis
Abbreviations: AN, Anorexia nervosa; ANBP, Anorexia nervosa binge purge; ANR, Anorexia nervosa restrictive; DSM-
IV, Diagnostic and statistical manual of mental disorders IV; EDE, Eating disorder examination; EDNOS, Eating
disorder not otherwise specified; GRP, Guideline relapse prevention; RPP, Relapse prevention plan; (SD)
BMI, (Standard deviation) Body mass index; SPSS, Statistical package for the social sciences
Background
Anorexia nervosa (AN) is a severe mental disorder with a
life-time prevalence among women of 2 % [1, 2] and high
mortality rates of 5 % per decade [2, 3]. Relapse is com-
mon among AN patients who previously showed full
remission of the eating disorder. Studies have reported a
wide range of estimates of relapse rates in AN, depending
upon the definitions of relapse used, the length of follow-
up, and the methodologies employed [4].
Relapse rates in studies with longer follow-up periods,
and without targeted prevention strategies differ from 6
to 57 % [5–11].
In three comparable studies on relapse prevention
with an average follow-up period of 18 months, full
relapse rates of 35, 41 and 41 % were found [4, 12, 13].
These studies demonstrated with survival analyses that
the highest risk of relapse was between 4 and 17 months
post-treatment. In the Netherlands, where also the
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present study has been conducted, research by Van
Elburg [14] showed a relapse rate of more than 50 %
over a period of five years. In none of these studies a
structured relapse prevention program was applied.
In leading guidelines in the field of eating disorders
[15–17], general consensus exists that relapse prevention
in patients with AN is essential. However, a major prob-
lem is the lack of structured methods for relapse preven-
tion to support professionals in clinical practice. Therefor
the Guideline Relapse Prevention Anorexia Nervosa
(GRP) was developed, intended for use by both profes-
sionals and patients to apply relapse prevention strategies
in a structured manner [18]. This Guideline was imple-
mented in specialized treatment setting for eating disor-
ders in The Netherlands.
The aim of the present study is to examine the rate,
timing and predictors of relapse of patients who were
treated with the GRP.
Method
Design
Cohort study of patients successfully treated for AN
included in a relapse prevention program for AN, with a
follow-up of 18 months.
Participants and setting
The following inclusion criteria were applied: in- and
outpatients, age 12 years and older, meeting the diagnos-
tic criteria of the DSM-IV [19] for AN or EDNOS clinic-
ally referred to as AN (for example women meeting all
criteria for AN, except that the individual has menses. In
33 cases the diagnosis was determined according to the
DSM-IV criteria and ascertained by eating disorder ex-
perts (all psychiatrists), supported by questions from the
EDE (Eating Disorder Examination) [20, 21]. In 50 cases
the actual EDE interview was administered to confirm
the eating disorder diagnosis that was determined by the
psychiatrist in accordance with the DSM-IV criteria.
Participants had successfully completed their treat-
ment, were weight restored with a normal (SD) BMI
based on their age and height. For inclusion it was fur-
ther required that they had drawn up a relapse preven-
tion plan (RPP) at the end of their treatment.
Ninety-six patients were eligible to participate in the
after-care program between 2009 and 2012, where the
Guideline Relapse Prevention Anorexia Nervosa (GRP)
was implemented. Thirteen participants did not meet
the inclusion criteria: seven participants did not have a
complete RPP, two patients were re-admitted for treat-
ment during the drafting of the RPP, two participants re-
fused to participate in the after-care program after making
a RPP, one patient moved abroad before starting the after-
care program, and one patient was admitted to a closed
ward during this study due to severe comorbidity (severe
depression with a risk of suicide). The remaining 83
participants were included in the analyses.
The study was carried out in a specialized treatment
center for eating disorders in the Netherlands, Altrecht
Eating Disorders Rintveld. The treatment provided in
this specialized setting is based on the state-of-the-art
evidence- and practice-based knowledge as described in
three guidelines: The Dutch Multidisciplinary Guideline
Eating Disorders [15], the NICE guidelines Eating Disor-
ders [16] and the American Psychiatric Association
Practice Guideline: Treatment of Patients with Eating
Disorders [17]. Treatment focuses on three areas: (1)
eating habits, body weight, and body image; (2) psycho-
logical aspects of functioning, such as self-esteem, per-
fectionism, and traumas; and (3) social functioning
within the family system and in society. In our center,
patients are basically treated on an outpatient basis, and
only admitted for short periods at a time, followed by
outpatient treatment. All patients who started the
relapse prevention program received prior outpatient
treatment. Only when remission was reached during
outpatient treatment were patients eligible for participa-
tion in the aftercare program. Comorbidity is managed
either in the center itself or by co-treatment in a differ-
ent specialized center.
Definition of relapse
In the present study the primary outcome was the oc-
currence of relapse. The distinction was made between
full and partial relapse. A full relapse was defined as:
BMI <18.5 for adults and SD BMI < -1 for adolescents,
together with full recurrence of the core diagnostic
symptoms of AN according to DSM-IV criteria, in the
first instance assessed by the professional, and next con-
firmed in a multidisciplinary consensus meeting. In case of
confirmation, this formed an indication for renewed treat-
ment. Partial relapse was defined as the re-occurrence of
one or more core diagnostic symptoms of AN, after a pre-
vious positive response to treatment. As a response to the
re-occurrence of symptoms, a temporary intensification of
the after-care program for a period up to three months
was needed to achieve full recovery again. If a longer in-
tensification of the program was needed the relapse was
classified as a full relapse.
The guideline relapse prevention anorexia nervosa (GRP)
The primary aim of the guideline is that the professional,
patient and her relatives work closely together to gain a
better understanding of the patient’s individual process
of relapse. Triggers and early warning signs that pre-
ceded previous relapses are identified and elaborated for
the individual patient, and actions are formulated that
can be performed in the event of a new impending re-
lapse. All this information is summarized in a Relapse
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Prevention Plan (RPP). The essence of the relapse pre-
vention strategy is to ensure that appropriate action is
taken as early as possible when early warning signs of
relapse occur.
The guideline is made up of three parts: (a) a theoretic
framework for relapse and relapse prevention, developed
on the basis of both the literature and practical experi-
ence of experts and patients, leading to conclusions and
recommendations for clinical practice; (b) a practical
manual for the professional; and (c) a workbook for
patients.
For a complete description of the application of the
GRP, see the case report by Berends, van Meijel & van
Elburg [22]. The GRP is freely accessible via the internet.
Drawing up a fully fledged relapse prevention plan re-
quires approximately six meetings of patient, relatives
and the professional. Practical experience with the appli-
cation of the GRP showed that individual sessions
should last approximately 45 min and should preferably
be scheduled every other week. After each session, the
patient receives homework assignments, to be carried
out either individually or together with relatives.
After a RPP is drawn-up, the aftercare-program starts.
This is a low-frequent individual program and has a
minimum duration of 18 months. During the aftercare-
visits the condition of the patient is thoroughly moni-
tored and discussed. Two scenarios can occur during
these visits: 1) The patient is stable, in which case the
focus is on maintaining this stable condition by promot-
ing good physical health and optimal personal and social
functioning. Actual or possible stressful life events in the
near future are discussed and anticipated on. 2) The pa-
tient shows one or more early signs of impending re-
lapse, in which case the main focus during the visit is on
obtaining a thorough understanding of the actual trig-
gers of relapse, and how to deal with these in order
to promote recovery. In this context specific arrange-
ments are made and actions are planned, based on
the content of the previously established relapse pre-
vention plan (RPP).
The frequency of the aftercare visits depends on the
patient’s condition and the need for treatment and care.
For example, patients who are stable will come for a visit
after four to six months. If the patient is less stable the
visits can be planned every two months. The patient and
the professional can decide to extend the aftercare
period after 18 months in case of prolonged vulnerability
to relapse, with a maximum of five years.
The visits last 45 min and are attended by both the pa-
tient and her relatives. At each visit the patient is weighed
and her condition is evaluated. During the visit, two main
topics are discussed, i.e., psychological and social function-
ing (school, friends, sports, overall moods, etc.) and the
presence of AN-symptoms (anorectic cognitions, abnormal
eating habits, excessive exercise pattern et cetera). Based
on this information, the RPP is updated if necessary. At the
end of the visit a new appointment is made for the next
visit. The patient’s record contains the following details of
each visit: weight, possible stage of relapse, and the ar-
rangements made during the visit.
Between the formal visits, a patient or her relatives
can contact the professional at any time in case of need
for help.
Data collection
Data were collected on:
1. Demographic and clinical characteristics: age, age of
onset, severity of the eating disorder, treatment duration,
duration of the eating disorder, BMI, in- or outpatient
treatment, number of sessions in the aftercare program,
subtype of AN (restrictive type (ANR) or binge/purging
type (ANBP)), and comorbidity (as ascertained by
psychiatrists at the start of treatment and confirmed in a
consensus meeting by the clinical team).
2. Data concerning full and partial relapse: weight,
stage of relapse, and the agreements made during
the visit.
– When a participant had a full relapse the
indication for renewed treatment was
documented.
– When a participant had a partial relapse the stage of
relapse was documented, as well as the intensification
of the aftercare-visits. When a participant
crossed the three-month duration of partial
relapse, it was registered as a full relapse.
Data-analysis
1. Kaplan-Meier survival analysis was used to analyze
the rate and timing of full relapse.
2. Demographic and clinical characteristics between
the group of patients with either full or partial
relapse, and the group of patients with no relapse
are presented with percentages and means.
3. In order to identify significant predictors of relapse,
Cox regression was used to assess the predictive
value of demographic and clinical characteristics
with respect to relapse. First, the variables were
tested univariate, after which predictors with a p-
value < .10 were entered in a multivariate Cox
regression model. SPSS for Windows (version 21.0)
was used to perform all statistical procedures.
Results
Baseline characteristics participants
The 83 participants had a mean age of 17.9 years
(SD = 4.45), measured at the start of the aftercare-
Berends et al. BMC Psychiatry  (2016) 16:316 Page 3 of 7
program. Their mean BMI was 16.4 kg/m2 (SD = 2.13)
at the start of the initial treatment, and 20.0 kg/m2
(SD = 1.54) at the end of treatment, which is at the
start of the aftercare-program. Since 58 participants
were younger than 19 years, SD BMI was collected
and therefor converted to BMI. The mean age of on-
set was 14.3 years (SD = 3.40). Of the participants
84.3 % (n = 70) was diagnosed with anorexia nervosa
restrictive type (ANR), and 15.7 % (n = 13) with an-
orexia nervosa binge purging type (ANBP). According
to the DSM-5 severity scale, 13.3 % of the partici-
pants had a mild disorder at the start of treatment,
18.1 % moderate, 12 % severe and 56.6 % extreme.
There were no significant differences between full and
partial relapsers concerning severity of the disorder.
The average time of participation in the aftercare-
program was 18.4 months (SD = 4.39). The mean
number of sessions during the aftercare program for
the non-relapse group was 4.14 (SD = 1.89) sessions;
for the partial relapse group it was significantly higher
at 6.69 (SD = 5.00) sessions (p = 0.008). For the full
relapse group, the mean number of sessions was 7.11
(SD = 7.49) sessions (p = 0.269).
Rate and timing of relapse
During the aftercare program, 10.8 % (n = 9) of the partici-
pants experienced a full relapse, whereas 19.3 % (n = 16)
had a partial relapse and 69.9 % (n = 58) did not relapse.
Figure 1 presents the survival curve for the 83 partici-
pants showing full relapse. No full relapses occurred in the
first four months of the program. The highest risk of full
relapse was between months 4 and 16. After 16 months
no full relapse occurred while 61 participants still partici-
pated in the aftercare-program at that point in time.
Identification of predictors of relapse
In order to identify significant predictors of relapse, first
univariable analyses were performed on demographic and
clinical characteristics (Tables 1 and 2). ‘Duration of treat-
ment’ (p = 0.007), ‘Type of treatment’ (p = 0.039) and ‘Age’
(p = 0.034) were the only variables to significantly predict
time until relapse. When entered in a multivariate Cox
Fig. 1 Survival function for full relapse
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regression model none of the variables were statistically
significant.
Discussion
The purpose of this study was to examine the rate, timing
and predictors of relapse in a group of recovered AN pa-
tients who participated in an aftercare-program using the
Guideline Relapse Prevention Anorexia Nervosa. The full
relapse rate for AN was 11 %, which is much lower than
the relapse rates found in previous studies with an average
follow-up period of 18 months, showing full relapse rates
of 35 % [4], 41 % [12] and 41 % [13]. In these studies no
structured methods for relapse prevention were applied.
Of the participants in the present study who experienced
the first signs of a relapse (30 %), 19 % recovered within a
three-month period and only 11 % relapsed fully. When ex-
periencing the first signs of relapse as described in their
RPP, these patients contacted their professional within a
week. It was therefore possible to intervene at an early stage,
guided by the predefined actions elaborated in the RPP.
Table 1 Demographic and clinical characteristics of the participants per group (full and partial relapse vs. non-relapse) including
outcome univariate Cox regression
Variable Full and partial
relapse group
(n = 25)
Non relapse group
(n = 58)
Univariate Cox
regression
p value
Univariate Cox
regression
Exp(B)
Onset eating disorder (years) 15.1 14.1 0.440 1.034
Duration of the eating disorder (years) 3.7 3.4 0.447 1.055
Duration of treatment before the aftercare-program (months) 25.6 16.2 0.007* 1.028
BMI at start treatment (kg/m2) 16.3 16.4 0.621 0.954
BMI at start of aftercare program 19.9 20.0 0.776 0.965
BMI at the end of aftercare program 19.9 20.4 0.166 0.865
Age 18 years or younger 22,4 % (n = 13) 77,6 % (n = 45) / /
Age 19 years or older 48 % (n = 12) 52 % (n = 13) 0.034* 2.344
Subtype ANBP 23.1 % (n = 3) 76.9 % (n = 10) / /
Subtype ANR 31.4 % (n = 22) 68.6 % (n = 48) 0.709 1.259
Type of treatment before the aftercare-program (patients
received only outpatient treatment)
32 % (n = 8) 56,9 % (n = 33) / /
Type of treatment before the aftercare-program (patients
received in- and outpatient treatment)
68 % (n = 17) 43.1 % (n = 25) 0.039* 2.425
Severity eating disorder DSM 5: Mild 16 % (n = 4) 12.1 % (n = 7) 0.764 1.179
Severity eating disorder DSM 5: Moderate 12 % (n = 3) 20.7 % (n = 12) 0.321 0.543
Severity eating disorder DSM 5: Severe 8 % (n = 2) 13.8 % (n = 8) 0.447 0.571
Severity eating disorder DSM 5: Extreme 64 % (n = 16) 53.4 % (n = 31) 0.266 1.591
Comorbidity 52 % (n = 13) 51.7 % (n = 30) 0.948 1.027
Anxiety disorder 0 % (n = 0) 6.9 % (n = 4) 0.458 0.046
Depressive disorder 24 % (n = 6) 8.6 % (n = 5) 0.151 1.963
Dysthymia 0 % (n = 0) 5.2 % (n = 3) 0.515 0.047
Obsessive compulsive disorder 0 % (n = 0) 6.9 % (n = 4) 0.426 0.046
Parent-child Relational Problem 24 %(n = 6) 19 % (n = 11) 0.363 1.533
Autism 0 % (n = 0) 1.7 % (n = 1) 0.660 0.048
Personality disorder 8 % (n = 2) 10.3 % (n = 6) 0.730 0.775
BMI body mass index, ANR anorexia nervosa restrictive, ANBP anorexia nervosa binge purge
*statistically significant
Table 2 BMI of the participants with a full relapse compared to the non full relapse group, including test outcome/statistics
Variable Full relapsed group
(n = 9)
Non full relapsed group
(n = 74)
T-test
p-value
Fisher’s exact test (2-sided)
p-value
BMI at start aftercare-program 19.46 20.07 0.12 –
BMI at the end of the aftercare-program 18.47 20.52 0.002* –
*statistically significant
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Although no definitive conclusions about the effective-
ness of the intervention can be drawn in this cohort
study, the findings support our hypothesis that working
with the guideline relapse prevention has a preventive
effect on the occurrence of full relapse in patients with
AN. When combining the rates of both partial and full
relapse, the percentage of 30 % is in the lower range of
relapse rates found in other studies.
The survival analysis shows the timing of full relapses
in this sample and indicates that within the first four
months after discharge (and after starting with the RPP)
no full relapses occurred, whilst the highest risk of full
relapse was between 4 and 16 months after discharge.
When combining the data concerning timing of partial
and full relapse, the findings indicate that the risk of re-
lapse is increased throughout the entire period of
18 months, suggesting that monitoring of early signs of
relapse is necessary during this complete period.
For the identification of predictors of relapse, the uni-
variate Cox regression between the two groups (the par-
tial and full relapse group versus the non-relapse group)
on demographic and clinical variables revealed that they
differed significantly on three variables. The first variable
was ‘Duration of treatment before the start of the after-
care program’. The longer a patient was in treatment,
the higher the risk of relapse. Duration of treatment
could point to relatively high vulnerability of patients
and severity of illness, thus leading to a higher risk of re-
lapse. This subgroup of patients should be offered extra
attention during aftercare, with proper information
about the increased risk of relapse, and intensive moni-
toring for a period of at least 18 months. The second
variable was ‘Type of treatment before the aftercare pro-
gram’, either outpatient treatment only or a combination
of in- and outpatient treatment. Patients who received
both in- and outpatient treatment had a higher risk of
relapse than patients who received outpatient treatment
only. It can be assumed that patients who require both
inpatient and outpatient treatment are more severely af-
fected by the eating disorder, compared to patients who
require outpatient treatment only, leading to a higher
risk of relapse. These findings are consistent with other
studies on relapse [6, 11, 12, 23]. The third variable
was’Age’. Patients older than 19 years had a higher risk
of relapse, based on the univariate regression analysis.
Previous studies also show higher relapse rates within
adults [4, 7–9, 11, 12]. In the end none of the variables
remained a significant predictor of relapse in the multi-
variate Cox regression analysis. The absence of unique
contribution of any of the predictors might be due to
correlation between these predictors.
A limitation of this retrospective study is that no stan-
dardized diagnostic instrument was used to determine re-
lapse or detect predictors of relapse. The determination of
relapse was based on BMI and the core diagnostic symp-
toms of AN according to the DSM IV, assessed by the
clinical expert on eating disorders and next confirmed in a
multidisciplinary consensus meeting. We do recommend
the use of a standardized diagnostic interview in future
prospective research to assess the occurrence of relapse.
The characteristics and variables used in our analyses were
collected from the participants’ files. For this reason we
could not explore the predictive value for relapse of
relevant variables. Future prospective research on pre-
dictors of relapse should include validated question-
naires to systematically examine these variables are
possible predictors of relapse.
These findings have clinical implications for relapse
prevention of AN. The general guidelines for the treat-
ment of AN lack methodological support in the practical
implementation of relapse prevention strategies in clin-
ical practice. From the present study, there are indica-
tions that the GRP provides an effective tool for relapse
prevention. Our tentative conclusion is that when early
recognition strategies are applied in case of impending
relapse, followed by targeted interventions to prevent
further deterioration, the risk of a full relapse will de-
crease. This increases the chance for patients to eventu-
ally reach a stable and lasting recovery. The low relapse
rate in our study supports the effectiveness of this strat-
egy, although a limitation of this study is the non-
experimental study design.
It is recommended to educate patients that the first
18 months after discharge is a high-risk period for re-
lapse, requiring continuous efforts to prevent relapse
using early recognition and intervention techniques.
Motivational techniques applied by professionals are
needed, in order for the patients to maintain awareness
of the increased risk of relapse, which with proper
preventive activities can be managed for a significant
proportion of cases.
The strength of this study is the relatively large sample
size of 83 participants. The research on relapse is scarce
and sample sizes are usually small. A limitation of this
study is the lack of a control group with randomization
of patients. Our study was set up to descriptively obtain
insight into relapse rates, timing and predictors. Despite
the positive trends we found in this study concerning
these relapse rates, the effectiveness of the guideline
could therefor not be determined unequivocally. Future
research would have to make use of a controlled study
design to confirm the effectiveness of the proposed
relapse prevention strategy.
Conclusions
Working with the relapse prevention guideline offers
structured support to prevent relapse in patients with
AN. We recommend that all patients with AN set up a
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RPP at the end of their treatment, with regular monitor-
ing for a period of at least 18 months after discharge. Pa-
tients gain a better understanding of the relapse process
when drawing up an RPP and working with it, enabling
them to develop self-management skills to independ-
ently influence the course of their illness and ultimately
prevent the occurrence of relapse.
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